TAM
VIVO

THB Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

THB Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.76M Sell
94,040
-10,933
-10% -$204K 0.4% 85
2020
Q3 		$1.78M Buy
104,973
+20,018
+24% +$389K 0.49% 75
2020
Q2 		$1.98M Buy
+84,955
New +$1.23M 0.57% 70

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

THB Asset Management's VIVO Position: Q4 2020 in Review

THB Asset Management reduced its Meridian Bioscience Inc (VIVO) stake by 10% in Q4 2020, selling an estimated $204K and leaving 94,040 shares worth $1.76M. The position accounts for 0.4% of the portfolio, ranked #85.

THB Asset Management first reported a position in VIVO in Q2 2020 and has held it in 3 quarters since. The position peaked at $1.98M in Q2 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • THB Asset Management held 94,040 shares of Meridian Bioscience Inc worth $1.76M as of Q4 2020.
  • THB Asset Management sold 10,933 Meridian Bioscience Inc shares in Q4 2020, an estimated $204K.
  • Meridian Bioscience Inc made up 0.4% of THB Asset Management's portfolio in Q4 2020, its #85 holding.
  • THB Asset Management first reported a position in Meridian Bioscience Inc in Q2 2020 and has held it in 3 quarters since.
  • THB Asset Management's Meridian Bioscience Inc position peaked at $1.98M in Q2 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.